Anti-schizophrenic drugs—Membrane receptor sites of action
- 1 October 1977
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 26 (19) , 1741-1748
- https://doi.org/10.1016/0006-2952(77)90340-9
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976
- The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist statesLife Sciences, 1975
- Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidolLife Sciences, 1975
- Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatumJournal of Pharmacy and Pharmacology, 1975
- Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compoundsJournal of Medicinal Chemistry, 1975
- Dopamin-Rezeptor-Blockade, ein möglicher Wirkungsmechanismus antipsychotisch wirksamer PharmakaPharmacopsychiatry, 1975
- Displacement of bound 14C-fluphenazine by biogenic amines and antipsychotic drugs in homogenates of brain tissueNature, 1974
- The Impulse-Blocking Concentrations of Anesthetics, Alcohols, Anticonvulsants, Barbiturates, and Narcotics on Phrenic and Sciatic NervesCanadian Journal of Physiology and Pharmacology, 1974
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Presynaptic Action of Central Depressant Drugs: Inhibition of Depolarization–Secretion CouplingCanadian Journal of Physiology and Pharmacology, 1972